Vasopressin antagonists in CHF: ready for clinical trials?

Short-Term Effects of Pecavaptan on Weight and Congestion in Acute Heart Failure: The AVANTI Post-Hoc Analysis.

JACC. Advances·2026

A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trial.

European journal of heart failure·2025

Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials.

Therapeutic advances in cardiovascular disease·2021

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.

Journal of cardiac failure·2020

Arginine vasopressin antagonism in heart failure: Current status and possible new directions.

Journal of cardiology·2019

Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.

European journal of heart failure·2018

Thyroid-stimulating hormone enhances platelet activation and arterial thrombosis.

Cardiovascular research·2026

JCAD/KIAA1462: biology, pathophysiology, and translational perspectives in vascular disease.

Cardiovascular research·2026

Sirt1 inhibits the recruitment of RNA polymerase II to metabolic gene promoter during pressure overload through competition with the preinitiation complex on Sub1.

Cardiovascular research·2026

Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy.

Cardiovascular research·2026

Inflammatory cytokines and immune signalling in heart failure: mechanisms, models and emerging therapies.

Cardiovascular research·2026

Timing of food intake impacts cardiovascular and neuroendocrine physiology and risk of disease.

Cardiovascular research·2026

Profiling of euphane and tirucallane triterpenes from Euphorbia systyloides on antichagasic activity reveals antileukemia and immunomodulatory effects.

Pharmaceutical biology·2026

Second-generation H1 antihistamines for the treatment of chronic urticaria: a network meta-analysis.

Frontiers in medicine·2026

Carbon dots derived from natural medicines: Therapeutic advances and challenges.

Journal of pharmaceutical analysis·2026

A Dual-Halogen Labeling Strategy to Detect and Quantify Double-Stranded RNAs Using NanoSIMS: A Proof-of-Concept Study.

ACS omega·2026

Design, Synthesis, and Dft Analysis of Benzaldehyde-Based Ethynyl-Functionalized Donor-Acceptor Dicyanomethyl Derivatives.

ACS omega·2026

Anti-hypoxic activity of Biyang floral mushroom polyphenols: deep eutectic solvent-based ultrasound-assisted extraction versus ethanol extraction.

Food science and biotechnology·2026

Related Experiment Videos

Vasopressin antagonists in CHF: ready for clinical trials?

Related Concept Videos

Short-Term Effects of Pecavaptan on Weight and Congestion in Acute Heart Failure: The AVANTI Post-Hoc Analysis.

A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trial.

Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials.

Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.

Arginine vasopressin antagonism in heart failure: Current status and possible new directions.

Direct comparison of ultrafiltration to pharmacological decongestion in heart failure: a per-protocol analysis of CARRESS-HF.

Thyroid-stimulating hormone enhances platelet activation and arterial thrombosis.

JCAD/KIAA1462: biology, pathophysiology, and translational perspectives in vascular disease.

Sirt1 inhibits the recruitment of RNA polymerase II to metabolic gene promoter during pressure overload through competition with the preinitiation complex on Sub1.

Free fatty acid receptor 4 in cardiac myocytes ameliorates ischemic cardiomyopathy.

Inflammatory cytokines and immune signalling in heart failure: mechanisms, models and emerging therapies.

Timing of food intake impacts cardiovascular and neuroendocrine physiology and risk of disease.

Profiling of euphane and tirucallane triterpenes from Euphorbia systyloides on antichagasic activity reveals antileukemia and immunomodulatory effects.

Second-generation H1 antihistamines for the treatment of chronic urticaria: a network meta-analysis.

Carbon dots derived from natural medicines: Therapeutic advances and challenges.

A Dual-Halogen Labeling Strategy to Detect and Quantify Double-Stranded RNAs Using NanoSIMS: A Proof-of-Concept Study.

Design, Synthesis, and Dft Analysis of Benzaldehyde-Based Ethynyl-Functionalized Donor-Acceptor Dicyanomethyl Derivatives.

Anti-hypoxic activity of Biyang floral mushroom polyphenols: deep eutectic solvent-based ultrasound-assisted extraction versus ethanol extraction.

Related Experiment Videos

Vasopressin antagonists in CHF: ready for clinical trials?

Related Concept Videos

Related Articles